Clinical Trial Update: The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial investigating nicotinamide riboside for skeletal muscle function in heart failure was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Heart Failure | Phase 2 | Status: TERMINATED | Results posted: 2020-10-28